Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Colorcon
Citi
Johnson and Johnson
Cantor Fitzgerald
AstraZeneca
Daiichi Sankyo
Teva
Chubb
QuintilesIMS

Generated: January 22, 2018

DrugPatentWatch Database Preview

NORMOSOL-M AND DEXTROSE 5% IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

When do Normosol-m And Dextrose 5% In Plastic Container patents expire, and what generic alternatives are available?

Normosol-m And Dextrose 5% In Plastic Container is a drug marketed by Icu Medical Inc and is included in one NDA.

The generic ingredient in NORMOSOL-M AND DEXTROSE 5% IN PLASTIC CONTAINER is dextrose; magnesium acetate; potassium acetate; sodium chloride. There are eight drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the dextrose; magnesium acetate; potassium acetate; sodium chloride profile page.

US Patents and Regulatory Information for NORMOSOL-M AND DEXTROSE 5% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Icu Medical Inc NORMOSOL-M AND DEXTROSE 5% IN PLASTIC CONTAINER dextrose; magnesium acetate; potassium acetate; sodium chloride INJECTABLE;INJECTION 017610-001 Approved Prior to Jan 1, 1982 RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
McKinsey
QuintilesIMS
Mallinckrodt
Federal Trade Commission
Farmers Insurance
Cerilliant
US Department of Justice
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot